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We developed an in vitro protein expression and interaction
analysis platform based on a highly parallel and sensitive
microfluidic affinity assay, and used it for 14,792 on-chip
experiments, which exhaustively measured the protein-protein
interactions of 43 Streptococcus pneumoniae proteins in
quadruplicate. The resulting network of 157 interactions was
denser than expected based on known networks. Analysis of the
network revealed previously undescribed physical interactions
among members of some biochemical pathways.
A key question in proteomics is how to measure the large number
of interactions in any given proteome. Even a small bacterial
genome has a few thousand genes, with millions of potential
protein-protein interactions. Many proteins also have multiple
roles in the cell. Understanding the multiplicity of interactions is
an essential requirement for systems biology and for computational
approaches to modeling the cell. However, current methods are
challenging enough that only a small number of prokaryotes have
been mapped in any depth. In most cases, only a small fraction of
the possible interactions have been found1–3. Many human patho-
gens, such as Streptococcus pneumoniae, have increasing antibiotic
resistance and are the source of many hospital infections4. Under-
standing protein interaction networks in these organisms may aid
the design of new antibiotics.
It is difficult to screen for protein-protein interactions. The yeast
two-hybrid (Y2H) method detects an interaction between two
proteins in the yeast nucleus5 and has been applied to large-scale
interaction mapping1–3,6,7. However, this method has disadvan-
tages. It cannot be used for membrane proteins, and the promis-
cuity of transcription factors poses a great challenge, leading to high
false positive rates. In addition, the overlap between the sets of
interactions discovered by independent Y2H studies of the same
organism’s interactome is negligible, with agreement on the order
of 1%7. Moreover, large-scale Y2H assay studies of Saccharomyces
cerevisiae and Caenorhabditis elegans found only 5–10% of the
expected interactions8. The sensitivities of these large studies are
generally not reported, although they are often calibrated by ‘weak’
control interactions (E2F1 binding to Rb) with 3 nM binding
constants9. A recent comparison between three ‘high-quality’ yeast
proteome studies had concluded that the low overlap between them
stems from low sensitivity10.
Methods that combine affinity purification with mass spectro-
metry can also be used to detect protein complexes. However, to
distinguish specific from nonspecific interactions, stringent wash
procedures are necessary, which could affect sensitivity. Moreover,
effectiveness of the purification tags may vary depending on the
organism11–13, and determining interconnectivity within the com-
plex is also difficult. The Y2H and affinity purification methods
show little overlap in Escherichia coli or S. cerevisiae protein
interaction screens1,6,8,10,14, suggesting that even for a relatively
simple bacterial model organism there is still a substantial portion
of the proteome that is not being sampled. Microarray-based
methods to screen for protein-protein interactions have also been
developed15. However, most current methods rely on depositing
purified proteins on the array, which hinders the design of a generic
screen. Moreover, arrays are also less likely to detect weak or
transient interactions owing to stringent wash requirements. An
emerging method to detect interacting proteins is the protein
complementation assay, but this requires one to be able to
genetically manipulate the target organism16.
We developed an in vitro microfluidic platform for high-
throughput screening of protein interactions, called protein inter-
action network generator (PING). PING combines on-chip in vitro
protein synthesis with an in situ microfluidic affinity assay. PING
uses our previously developed mechanical trapping of molecular
interactions (MITOMI), which allows one to measure interactions
without prey losses owing to washing, and can thus detect weak or
transient interactions17. For PING, a co-spotted DNA microarray
containing linear template encoding the proteins is aligned and
bonded with the microfluidic device (Fig. 1a,b and Supplementary
Fig. 1 online). One can therefore easily express thousands of
protein combinations (either binary or complex) on a single device
without the need for purification or prior knowledge of protein
oligomeric state. The experiment consists of three main stages: (i)
we use biotinylated BSA and streptavidin to deposit a biotinylated
antibody that recognizes the bait protein on a circular area inside
each individual chamber; (ii) we express proteins in vitro by filling
each chamber with an E. coli extract that allows transcription and
translation of the spotted DNA; (iii) the bait is immobilized on the
chamber surface, and we measure any interactions between bait
and prey using fluorescently labeled antibodies and MITOMI
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(Supplementary Methods online). In vitro protein expression
prevents complications otherwise caused by cell viability or phy-
siology, and PING enables a direct biophysical measurement of
interactions for various proteins. Unlike other self-assembling
protein array methods, each reaction occurs in its own unit
cell, and there are hence no limitations resulting from cross-
contamination or diffusion18 (Fig. 1b,c).
We used this device to explore interactions in the S. pneumoniae
proteome by measuring all possible pairwise interactions in the set
of proteins with at least one previously annotated interaction in
Swissprot (Supplementary Table 1 online). These proteins include
32 homodimers, six heterodimers and five monomers. To estimate
how weak an interaction PING can measure, we engineered an
enhanced GFP (eGFP) construct with a 4His tag at its N terminus
and measured its binding to an antibody to 5His (anti-5His); anti-
5His binding to the 4His tag is known to be weak. Using PING, we
found the binding constant to be 884 ± 158 nM (Supplementary
Figs. 2 and 3 online), which sets the detection limit of PING as
better than 0.9 mM. To further investigate this, we measured the
affinity of the yeast transcription factor Pho4p for 256 DNA
sequences, for which absolute affinities are known17. Again, we
found a lower detection limit for PING near 1 mM, confirming the
4His-eGFP results. The existence of multimeric interactions com-
plicates estimations of affinity of a protein-protein interaction,
so the sensitivity of PING depends on the type of interaction (that
is, the oligomeric state of the bait and prey) and cannot necessarily
be captured in a single measurement. The 1 mM value is a rough
estimate of sensitivity.
We characterized the on-chip expression profile of the set of 43
S. penumoniae proteins. All 43 proteins were expressed, with about
4 fold difference between lowest and highest expression levels
(Fig. 2a). There was no correlation between protein size and
expression (Fig. 2b–d). This shows that on-chip expression is not
limited by size (within the range of 35–757 amino acids). We also
found no correlation between the variation in protein expression
(8%) and protein size (Fig. 2e). There were only 4 outlier proteins
with large s.d. between experiments. Our dataset contains DNA-
binding proteins (for example, SP2112), for which PING detected
interactions. Recently, we had also demonstrated that this PING
chip could be used to detect membrane protein-nucleic acid
interactions19. Taken together, these results highlight the broad
spectrum of proteins that can be investigated with PING.
Next, we measured all possible pair-wise interactions between the
43 S. pneumoniae proteins (Supplementary Data 1 online). Bait-
only and prey-only wells served as controls for nonspecific signals
similar to Y2H or immunoprecipitation experiments. We used
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Figure 1 | Experimental design. (a) Graphical representation of expression
template design. Both bait and prey DNA templates include a T7 promoter,
ribosome binding site (RBS), poly(A) and T7 terminator. The bait library
includes a c-myc tag for measuring expression and a T7 tag for protein
pull-down. The prey library includes a His tag for detecting interactions.
(b) Schematic of the device layout. Each unit cell is controlled by three
micromechanical valves as well as a ‘button‘ membrane used for surface
derivatization and MITOMI. Bait and Prey DNA templates are aligned under
the chip’s DNA chambers in which proteins are expressed. Pull-down antibody
is deposited under the button valve. Unit cell size is 281.25 mm by 562.5 mm
and an area of 158,203 mm2. Average cell height is 10 mm, and average cell
volume is less than 1 nl. Unit cell density is 632 cm–2. (c) Image of a typical
bait (green) and prey (red) interaction on chip. Interaction is in orange
owing to overlay of the two channels. Scale bar, 100 mm.
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Figure 2 | On-chip protein expression. (a) Protein expression levels (in
arbitrary fluorescence units) of 43 different S. pneumoniae proteins were
measured with Cy3-labeled antibody to c-myc. Error bars, s.e.m. n ¼ 4.
(b) Expression levels as a function of protein size. (c) Variation in expression
levels (s.d.) as a function of protein size. (d,e) Distribution histograms of
protein expression levels (d) and protein size (e) in the 43-protein set.
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strict cutoffs: we considered any signal 2 s.d. above the bait-only
average an interaction (prey-only had negligible signals). To reduce
false positive interactions, we switched the roles of bait and prey
and repeated the experiment. We considered only bidirectional
interactions ‘positive’ (157/204 interactions). To confirm the sig-
nificance of our cutoffs, we compared the negative interactions to
the positive control (known) interactions using a nonparametric
Mann-Whitney U test. The difference between the two datasets in a
two-tailed test was highly significant (Po 2  106; Supplemen-
tary Table 2 online). We presented the results in a three-
dimensional plot of the interaction strength as a function of bait
and prey expression (Fig. 3) or as a histogram of the interaction
strengths (Supplementary Fig. 4 online) with similar results. We
performed a total of 14,792 individual experiments, encompassing
all 1,849 possible interactions, with an experiment in each
‘direction’ performed in quadruplicate.
The S. pneumoniae network that we constructed consisted of a
total of 43 nodes and 157 edges (Fig. 4 and Supplementary Table 3
online). We confirmed 157 out of 204 edges (77%) in the second
scan (bait and prey reversed). The network contained 24/38 (63%)
interactions annotated in the Swissprot database. None of the five
proteins known to be monomers (negative controls) formed
interactions with themselves, although we did discover interactions
with other proteins in the set. As expected, the largest nodes were
four heat-shock proteins, which were responsible for 61 edges. The
largest node belonged to GroEL heat-shock complex, which is
notorious for promiscuous binding1. There were 96 specific inter-
actions in the network that did not involve the heat shock proteins.
The network had an average of 3.6 interactions per protein. The
average number of interactions per protein published in the
Database of Interacting Proteins for E. coli is 4.0 (http://dip.
doe-mbi.ucla.edu/dip/Stat.cgi/).
The false negative rate of PING was 37% (14 false negatives out
of a total of 38 known interactions), if we assume the Swissprot
annotations to be correct; in Y2H, the false negative rate has
been variously estimated as 43%–71%20. To estimate the false
positive fraction of PING interactions, we retested a small set of
‘positive’ but previously uncharacterized interactions, using co-
immunoprecipitation. We also tested six known interactions as a
positive control and used a pair of known noninteracting proteins
as negative control (Fig. 3b). All 12 expected ‘positives’ co-
immunoprecipitated but the negative control did not. Based on
the fact that there were no false positives in the group of six new
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Figure 3 | Analysis of protein-protein interactions. (a) A three-dimensional plot of protein interactions as a function of bait and prey expression. Interactions
(in arbitrary fluorescence units) are represented by spheres: specific or bidirectional interactions (blue), nonspecific or unidirectional interactions (gold),
’confirmed interactions‘ from the SwissProt database detected by PING (red) and SwissProt interactions that PING failed to detect (cyan). The cutoff was
determined as 2 s.d. above the average signal resulting from anti-HIS binding to the corresponding bait-only expressing cells. (b) Verification of protein
interactions by co-immunoprecipitation experiments. Six pairs of known interactors, six pairs of previously unknown interactors and one pair of proteins that do
not interact were tested. Bait and prey protein pairs were co-expressed in vitro and then co-immunoprecipitated using Nickel beads. Prey levels were detected
with Alexa 647-labeled antibody to the T7 tag. The data were plotted as net signal, in units of s.d. of the background.
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Figure 4 | S. pneumoniae interaction network represented by a hairball graph
created with Cytoscape 2.4. Blue edges represent interactions found by PING
screens. Red edges represent confirmed interactions from the Swissprot
database. Heat shock proteins were omitted for clarity.
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interactions, we estimated an upper limit of false positive fraction at
40%; the actual number may in fact be much lower. For Y2H, the
false positive fraction can range from 47% to 91%20.
If PING was biased toward highly expressed proteins, we would
expect fewer interactions for proteins with low expression, whereas
highly expressed proteins would have more interactions. To exam-
ine such possible bias, we examined ten proteins with low expres-
sion and ten proteins with high expression. The average number of
interactions for proteins with high expression was 4.2 ± 2.2 and for
those with low expression it was 4.2 ± 4.0. In fact, three highly
expressing proteins (SP0894, SP2121 and SP2229) had no detect-
able interactions at all. Therefore, we conclude that PING has no
considerable bias toward highly expressed proteins (Supplemen-
tary Table 4 online).
Notably, we found some examples of previously undescribed
physical interactions between proteins in the same biochemical
pathway. For instance, asparagine synthetase (asnS) and tRNA
amidotransferase (gatA) are involved in the alanine and aspartate
metabolism pathways, and are seen to interact by PING. asnS
controls conversion of aspartate to asparagine, and the gatABC
complex can create asparagine tRNAs through a secondary path-
way21. The AsnS-GatA interaction may be part of a feedback
mechanism for the asparagine tRNA synthesis pathway. A second
example is the interaction between dihydroorotate dehydrogenase
(pyrD), which is involved in pyrimidine metabolism, and pyrimi-
dine operon regulatory protein (pyrR). A potential physical inter-
action between these proteins also suggests a possible feedback
mechanism. There are also interactions that are not as obvious to
rationalize based on existing gene annotations. Many of these may
well be ‘moonlighting’ proteins, which perform multiple appar-
ently unrelated functions22.
PING begins with a clone library, but all subsequent steps are
in vitro. For most common uses, in vitro expression either cannot
generate enough protein or is prohibitively expensive. However, the
economies of scale achieved with microfluidics allow us to express,
purify and concentrate thousands of proteins in parallel. Each
experiment begins with 50–100 pg of DNA template and is
performed in a 1 nl volume. Taking into account the total volume
of lysate used per device, only 2 nl of reagent is consumed per
reaction, and costs are low. This approach to protein expression and
screening is quite general and may be used in other applications.
In summary, using PING to study a subset of protein-protein
interactions in S. pneumonia, we found that despite many years of
research on this organism, conventional approaches discovered
only a fraction of the interactions in this set of proteins. A
surprisingly rich network of interactions exists, and our results
suggest hypotheses about feedback within various metabolic
pathways and indicate that many proteins may be involved in
multiple functions.
Note: Supplementary information is available on the Nature Methods website.
ACKNOWLEDGMENTS
We thank members of the Stanford microfluidics foundry for help with device
fabrication. This work was supported in part by the US National Institutes of
Health Director’s Pioneer award (to S.R.Q.) and a Fulbright award (to D.G.).
COMPETING INTERESTS STATEMENT
The authors declare competing financial interests: details accompany the full-text
HTML version of the paper at http://www.nature.com/naturemethods/.
Published online at http://www.nature.com/naturemethods/
Reprints and permissions information is available online at
http://npg.nature.com/reprintsandpermissions/
1. Arifuzzaman, M. et al. Genome Res. 16, 686–691 (2006).
2. Parrish, J.R. et al. Genome Biol. 8, R130 (2007).
3. Shimoda, Y. et al. DNA Res. 15, 13–23 (2008).
4. Hyde, T.B. et al. J. Am. Med. Assoc. 286, 1857–1862 (2001).
5. Fields, S. & Song, O. Nature 340, 245–246 (1989).
6. Aloy, P. & Russell, R.B. Trends Biochem. Sci. 27, 633–638 (2002).
7. Parrish, J.R., Gulyas, K.D. & Finley, R.L. Jr. Curr. Opin. Biotechnol. 17, 387–393
(2006).
8. Cusick, M.E., Klitgord, N., Vidal, M. & Hill, D.E. Hum. Mol. Genet. 14 (Special issue
2), R171–R181 (2005).
9. Lee, C., Chang, J.H., Lee, H.S. & Cho, Y. Genes Dev. 16, 3199–3212
(2002).
10. Yu, H. et al. Science 322, 104–110 (2008).
11. Deshaies, R.J. et al. Mol. Cell. Proteomics 1, 3–10 (2002).
12. Rigaut, G. et al. Nat. Biotechnol. 17, 1030–1032 (1999).
13. Ho, Y. et al. Nature 415, 180–183 (2002).
14. Butland, G. et al. Nature 433, 531–537 (2005).
15. Zhu, H. et al. Science 293, 2101–2105 (2001).
16. Tarassov, K. et al. Science 320, 1465–1470 (2008).
17. Maerkl, S.J. & Quake, S.R. Science 315, 233–237 (2007).
18. Ramachandran, N. et al. Science 305, 86–90 (2004).
19. Einav, S. et al. Nat. Biotechnol. 26, 1019–1027 (2008).
20. Edwards, A.M. et al. Trends Genet. 18, 529–536 (2002).
21. Curnow, A.W., Tumbula, D.L., Pelaschier, J.T., Min, B. & Soll, D. Proc. Natl. Acad.
Sci. USA 95, 12838–12843 (1998).
22. Gancedo, C. & Flores, C.L. Microbiol. Mol. Biol. Rev. 72, 197–210 (2008).
 
 p
u
or
G
 g
n ih si lb
uP
 er
u ta
N
 800 2
©
e r
ut a
n/
m
oc
.
er
ut a
n
.
w
w
w//:ptth
s
d
o
ht
e
m
4 | ADVANCE ONLINE PUBLICATION | NATURE METHODS
BRIEF COMMUNICATIONS
